Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
374M
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
27.4M
-
Shares change
-
+1.28M
-
Total reported value, excl. options
-
$925M
-
Value change
-
+$53.4M
-
Put/Call ratio
-
1.02
-
Number of buys
-
60
-
Number of sells
-
-44
-
Price
-
$33.73
Significant Holders of STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) as of Q4 2014
124 filings reported holding LAB - STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share as of Q4 2014.
STANDARD BIOTOOLS INC. - Common Stock, par value $0.001 per share (LAB) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27.4M shares
of 374M outstanding shares and own 7.33% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (3.73M shares), JENNISON ASSOCIATES LLC (3.09M shares), ORBIMED ADVISORS LLC (2.14M shares), FRANKLIN RESOURCES INC (2.01M shares), WASATCH ADVISORS INC (1.99M shares), NEXT CENTURY GROWTH INVESTORS LLC (1.52M shares), FMR LLC (1.23M shares), LORD, ABBETT & CO. LLC (1.19M shares), VANGUARD GROUP INC (892K shares), and BlackRock Fund Advisors (876K shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.